- Clinically validated, advanced surgical robotics technology platform.
- Differentiated SSi Mantra system attributes (e.g., cost advantages, cardiac and pediatric surgery capabilities, ease of use and training, and pioneering telesurgery features).
- Large and growing addressable market with favorable industry tailwinds.
- Stronghold in India, global expansion underway, and potential catalysts in the US and EU.
- World-class R&D and manufacturing facilities to support growth.
- Robust sales growth, expanding margins, and increasing mix of recurring revenue.
- Aligned, accomplished management team and Board of Directors.
SS Innovations International (NASDAQ: SSII) develops differentiated surgical robotic technologies, highlighted by its advanced, cost-efficient SSi Mantra surgical robotic system. Spearheaded by a team of visionary engineers and Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company’s founder, Chairman and Chief Executive Officer, the SSi Mantra features differentiated capabilities in areas such as telesurgery, cardiac surgery and pediatric procedures. The SSi Mantra’s broad-based surgical robotic applications, modularity, user friendliness, training capabilities, clinical track record and relative cost advantages have contributed to its early commercial success.
Questions around this news
What capabilities does the SSi Mantra surgical robotic system offer?
The release describes the SSi Mantra as a surgical robotic system with capabilities that include telesurgery, cardiac surgery and pediatric procedures. It also highlights broad surgical applications, a modular design, user friendliness, training capabilities and relative cost advantages. The release attributes the system’s early commercial success to these features and its clinical track record.
Where is SS Innovations based, and where is it expanding?
The release says SS Innovations is headquartered in India and is expanding globally. It also points to potential catalysts in the United States and European Union, but does not provide details about specific expansion milestones, markets entered or timelines. The company describes its broader aim as widening access to advanced surgical robotic technologies.
What is telesurgery?
Telesurgery is surgery in which a surgeon controls robotic instruments from a location separate from the patient. The system relays the surgeon’s movements to instruments at the operating site, often using a communications link. Its use depends on suitable equipment, reliable connectivity, clinical protocols and regulatory requirements.
What does recurring revenue mean?
Recurring revenue is income a business receives repeatedly from ongoing customer relationships, rather than only from one-time sales. It can come from subscriptions, service agreements or other continuing arrangements. The term describes the pattern of revenue; it does not by itself indicate how much revenue a company earns or whether it is profitable.
SS Innovations is a rapidly growing American company headquartered in India and expanding globally with an eye on democratizing access to cutting-edge surgical robotic technologies. After commencing commercial operations in late 2022, the company’s annual revenue has grown from approximately…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]
At a glance
- Company
- SS Innovations International
- Ticker
- NASDAQ: SSII
- Location
- India
People
- Dr. Sudhir SrivastavaFounder, Chairman and Chief Executive Officer
